Trial · NCT04445987
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Cohort 1 Group 1: ARQ-154-203 Roflumilast Foam 0.3% Without Treatment Gap | 52 | |
| Overall Study | STARTED | Cohort 1 Group 1: ARQ 154-203 Vehicle Foam Rolled Over Without Treatment Gap | 23 | |
| Overall Study | STARTED | Cohort 2 Group 3: ARQ-154-203 Roflumilast Foam 0.3% With Treatment Gap | 41 | |
| Overall Study | STARTED | Cohort 2 Group 3: ARQ-154-203 Vehicle Foam With Treatment Gap | 17 | |
| Overall Study | STARTED | Cohort 2 Group 4: De Novo Participants | 267 | |
| Overall Study | STARTED | Cohort 1 Group 2: ARQ-154-116 Rollover | 8 | |
| Overall Study | COMPLETED | Cohort 1 Group 1: ARQ-154-203 Roflumilast Foam 0.3% Without Treatment Gap | 43 | |
| Overall Study | COMPLETED | Cohort 1 Group 1: ARQ 154-203 Vehicle Foam Rolled Over Without Treatment Gap | 20 | |
| Overall Study | COMPLETED | Cohort 2 Group 3: ARQ-154-203 Roflumilast Foam 0.3% With Treatment Gap | 37 | |
| Overall Study | COMPLETED | Cohort 2 Group 3: ARQ-154-203 Vehicle Foam With Treatment Gap | 16 | |
| Overall Study | COMPLETED | Cohort 2 Group 4: De Novo Participants | 211 | |
| Overall Study | COMPLETED | Cohort 1 Group 2: ARQ-154-116 Rollover | 7 | |
| Overall Study | NOT COMPLETED | Cohort 1 Group 1: ARQ-154-203 Roflumilast Foam 0.3% Without Treatment Gap | 9 | |
| Overall Study | NOT COMPLETED | Cohort 1 Group 1: ARQ 154-203 Vehicle Foam Rolled Over Without Treatment Gap | 3 | |
| Overall Study | NOT COMPLETED | Cohort 2 Group 3: ARQ-154-203 Roflumilast Foam 0.3% With Treatment Gap | 4 | |
| Overall Study | NOT COMPLETED | Cohort 2 Group 3: ARQ-154-203 Vehicle Foam With Treatment Gap | 1 | |
| Overall Study | NOT COMPLETED | Cohort 2 Group 4: De Novo Participants | 56 | |
| Overall Study | NOT COMPLETED | Cohort 1 Group 2: ARQ-154-116 Rollover | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04445987/flow